Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
473.6 GBX | +0.42% | +6.86% | -2.75% |
07/05 | AstraZeneca target raised; Antofagasta lowered | AN |
19/04 | Peel Hunt starts NatWest and Barclays at 'buy' | AN |
Sales 2024 * | 184.1Cr 231.78Cr 19TCr | Sales 2025 * | 198.13Cr 249.43Cr 21TCr | Capitalization | 147.99Cr 186.32Cr 16TCr |
---|---|---|---|---|---|
Net income 2024 * | 6.4Cr 8.06Cr 672.5Cr | Net income 2025 * | 9.1Cr 11Cr 956.21Cr | EV / Sales 2024 * | 0.8 x |
Net cash position 2024 * | 81.2L 1.02Cr 85Cr | Net cash position 2025 * | 1.37Cr 1.72Cr 143.44Cr | EV / Sales 2025 * | 0.74 x |
P/E ratio 2024 * |
23.2
x | P/E ratio 2025 * |
15.7
x | Employees | 7,859 |
Yield 2024 * |
5.08% | Yield 2025 * |
6.04% | Free-Float | 94.58% |
Latest transcript on PageGroup plc
1 day | +0.38% | ||
1 week | +6.86% | ||
Current month | +6.14% | ||
1 month | -2.19% | ||
3 months | +5.38% | ||
6 months | +12.33% | ||
Current year | -2.75% |
Managers | Title | Age | Since |
---|---|---|---|
Nicholas Kirk
CEO | Chief Executive Officer | - | 01/23/01 |
Director of Finance/CFO | 52 | 01/06/01 | |
Kaye Maguire
LAW | General Counsel | - | 17/18/17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marie Metayer
BRD | Director/Board Member | 64 | 01/17/01 |
Director of Finance/CFO | 52 | 01/06/01 | |
Karen Geary
BRD | Director/Board Member | - | 01/22/01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 746 M€ | -.--% | - | |
0.01% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
14/24/14 | 473.6 | +0.42% | 749 161 |
13/24/13 | 471.6 | +0.55% | 221,672 |
10/24/10 | 469 | +3.17% | 357,140 |
09/24/09 | 454.6 | +2.85% | 524,706 |
08/24/08 | 442 | -1.07% | 333,857 |
Delayed Quote London S.E., May 14, 2024 at 09:05 pm IST
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.75% | 185.76Cr | |
+9.18% | 337.24Cr | |
-6.87% | 199.72Cr | |
+17.64% | 68Cr |
- Stock Market
- Equities
- MPI Stock